Blockchain Registration Transaction Record

Medicus Pharma CEO Announces Updated Phase 2 Clinical Protocol Submission to FDA

Medicus Pharma CEO announces submission of an updated Phase 2 clinical protocol to FDA for non-invasive skin cancer treatment

Medicus Pharma CEO Announces Updated Phase 2 Clinical Protocol Submission to FDA

This news matters as it signifies advancements in non-invasive skin cancer treatment, potentially improving patient outcomes and showcasing the company’s commitment to innovative technology and rigorous research.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x1b9a229190918c96f4e5792577d4259046f22c00cfacf1a6f60a7e060a43f1bd
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintwolfyy_W-fc33279f9a237c6cd79410923e5f4017